» Articles » PMID: 37831311

Histiocytoid Cardiomyopathy Presenting As Sudden Death in an 18-month-old Infant

Overview
Date 2023 Oct 13
PMID 37831311
Authors
Affiliations
Soon will be listed here.
Abstract

Histiocytoid cardiomyopathy (HC) is an arrhythmogenic disorder, usually involving children under two years of age with a strong Caucasian and female predominance. The disease is fatal in the vast majority and diagnosis is nearly always established at autopsy, but this is only possible with adequate myocardial sampling. Meticulous gross and histological examination of the heart in collaboration with a cardiovascular-trained pathologist maximises the opportunity to make specific diagnoses (and therefore rule out the differentials of SIDS, SUDC and child abuse), guide genetic testing, and inform potentially life-saving medical interventions for blood relations. We present a typical HC case presenting as sudden death, without prodrome, in a previously healthy 18-month-old boy. The disease is characterised histologically by discrete groups of enlarged, polygonal histiocyte-like cells with distinct margins and abundant faintly eosinophilic foamy cytoplasm. Cells often contain coarse granules, microvacuoles and irregular, round nuclei. In our case, dysplastic fascicles were predominantly located immediately deep to the endocardium of the left ventricle. We report our own autopsy findings with histological images, and discuss the expected clinical, morphological and ultrastructural features of the disease.

Citing Articles

Cardiac Tumors Causing Sudden Cardiac Death: A State-of-the-Art Review in Pathology.

Salzillo C, Luca S, Ronchi A, Franco R, Iacobellis G, Leggio A Cancers (Basel). 2025; 17(4).

PMID: 40002264 PMC: 11853695. DOI: 10.3390/cancers17040669.

References
1.
Fellmann F, van El C, Charron P, Michaud K, Howard H, Boers S . European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death. Eur J Hum Genet. 2019; 27(12):1763-1773. PMC: 6870982. DOI: 10.1038/s41431-019-0445-y. View

2.
Maron B, Towbin J, Thiene G, Antzelevitch C, Corrado D, Arnett D . Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and.... Circulation. 2006; 113(14):1807-16. DOI: 10.1161/CIRCULATIONAHA.106.174287. View

3.
Shehata B, Bouzyk M, Shulman S, Tang W, Steelman C, Davis G . Identification of candidate genes for histiocytoid cardiomyopathy (HC) using whole genome expression analysis: analyzing material from the HC registry. Pediatr Dev Pathol. 2011; 14(5):370-7. PMC: 3295543. DOI: 10.2350/10-05-0826-OA.1. View

4.
Shehata B, Cundiff C, Lee K, Sabharwal A, Lalwani M, Davis A . Exome sequencing of patients with histiocytoid cardiomyopathy reveals a de novo NDUFB11 mutation that plays a role in the pathogenesis of histiocytoid cardiomyopathy. Am J Med Genet A. 2015; 167A(9):2114-21. PMC: 4753789. DOI: 10.1002/ajmg.a.37138. View

5.
Burke A, Tavora F . The 2015 WHO Classification of Tumors of the Heart and Pericardium. J Thorac Oncol. 2016; 11(4):441-52. DOI: 10.1016/j.jtho.2015.11.009. View